Newsbenzinga
BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…